New study: Montreal researchers identify three drugs that could reduce mortality in severely ill COVID-19 patients
Researchers from the RI-MUHC and the McGill Genome Centre examine...
Improving the performance of rapid tests through clear instructions
Researchers at the RI-MUHC investigate whether rapid antigenic detection tests for COVID-19 could be adequately used in the workplace.
Jesse Papenburg wins Principal’s Prize for sharing the science behind COVID-19
Leading McGill scholars celebrated for sharing their work with the media
COVID-19 vaccination highly effective in individuals with immune-related inflammatory diseases
RI-MUHC researcher Sasha Bernatsky is senior author of a nationwide study
$6.7 million to study the impacts of COVID-19 on children
Health Minister Jean-Yves Duclos visits Montreal to announce a new investment in pediatric research and to congratulate researcher...
Five RI-MUHC researchers receive new funding from MI4
Cutting-edge projects in infection and immunity supported in Round 4 of MI4’s Seed Fund Grant program
Nadine Kronfli receives 2021 AMMI Canada New Investigator Award
RI-MUHC researcher confronts the unique challenges of eliminating infectious diseases in prisons
Benefits of fluvoxamine confirmed in new study
Preventing hospitalization following COVID-19 infection in vulnerable populations
TB and COVID-19, a joint battle?
On World TB Day 2022, we are looking at how researchers from the McGill International TB Centre at the RI-MUHC are working to raise awareness and to put an end to TB.
Cecilia Costiniuk receives 2022 CAHR-CANFAR Excellence in Research Award
RI-MUHC researcher is committed to improving the lives of those living with HIV